Search

Riccardo Manetti

from Brookline, MA
Age ~66

Riccardo Manetti Phones & Addresses

  • 26 Egmont St, Brookline, MA 02446 (617) 383-5578
  • 145 Babcock St, Brookline, MA 02446 (617) 383-5578

Work

Company: Novartis vaccines and diagnostics Jan 2013 Address: Basel, Switzerland Position: Global head, business development and licensing

Education

Degree: PhD School / High School: Università degli Studi di Padova 1995 to 1998 Specialities: Cellular and Molecular Biology and Pathology

Industries

Pharmaceuticals

Resumes

Resumes

Riccardo Manetti Photo 1

Global Head, Business Development And Licensing At Novartis Vaccines And Diagnostics

View page
Position:
Global Head, Business Development and Licensing at Novartis Vaccines and Diagnostics
Location:
Basel Area, Switzerland
Industry:
Pharmaceuticals
Work:
Novartis Vaccines and Diagnostics - Basel, Switzerland since Jan 2013
Global Head, Business Development and Licensing

Novartis Vaccines and Diagnostics Aug 2010 - Dec 2012
Head, Negotiations

Novartis Vaccines and Diagnostics Apr 2006 - Feb 2009
Head, Business Development, Search and Evaluation, Research and Technologies

Chiron Vaccines spa - Siena, Italy Jan 2004 - Apr 2006
Director Business Development, Emerging Opportunities

Chiron Vaccines spa - Siena, Italy Sep 2001 - Dec 2003
Business Development Manager
Education:
Università degli Studi di Padova 1995 - 1998
PhD, Cellular and Molecular Biology and Pathology
Università degli Studi di Siena 1989 - 1993
Laurea, Biology

Publications

Us Patents

Adjuvant-Sparing Multi-Dose Influenza Vaccination Regimen

View page
US Patent:
20120039934, Feb 16, 2012
Filed:
Sep 19, 2011
Appl. No.:
13/236538
Inventors:
Giuseppe DEL GIUDICE - Siena, IT
Riccardo Manetti - Cambridge MA, US
Assignee:
NOVARTIS AG - Basel
International Classification:
A61K 39/145
A61P 37/04
US Classification:
4242101, 4242091
Abstract:
An influenza vaccine is administered by a multi-dose regimen, in which (i) a first dose is administered with an adjuvant and (ii) a later dose is administered either without an adjuvant or with a different adjuvant. Thus the invention provides the benefits of a two-dose regimen without also doubling the supply need for a given adjuvant.

Adjuvant-Sparing Multi-Dose Influenza Vaccination Regimen

View page
US Patent:
20090220545, Sep 3, 2009
Filed:
Jun 15, 2007
Appl. No.:
12/304919
Inventors:
Giuseppe Del Giudice - Siena, IT
Riccardo Manetti - Cambridge MA, US
Assignee:
NOVARTIS AG - BASEL
International Classification:
A61K 39/145
US Classification:
4242091
Abstract:
An influenza vaccine is administered by a multi-dose regimen, in which (i) a first dose is administered with an adjuvant and (ii) a later dose is administered either without an adjuvant or with a different adjuvant. Thus the invention provides the benefits of a two-dose regimen without also doubling the supply need for a given adjuvant.
Riccardo Manetti from Brookline, MA, age ~66 Get Report